Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × dactolisib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

dactolisib 1 Surveys and Questionnaires 1 Photochemotherapy 1 PM 01183 1 Irinotecan 1 Fentanyl 1 Everolimus 1 Dihematoporphyrin Ether 1 Biological Factors 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01508104 2017-08-23

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

University of Cincinnati

Phase 1 Terminated

CNSEndocrineNET

Brain Neoplasms, Glioblastoma, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡